13F filer · CIK 1422848 ↗
Capital Research Global Investors
You are looking at Q1 2020. See the latest, Q2 2026 →
Reported value
$254.90B
−24% on the quarter before
Positions
397
41 new · 49 sold out
Top 10
34.9%
of the value
Est. gain
−$52.42B
on stocks held all quarter
Est. return
−18.6%
on those stocks since Q4 2019
Positions as of Mar 31, 2020, from Capital Research Global Investors's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.
Portfolio at a glance
- New
- Added
- Cut
- Same
- Options
The 24 largest positions, 51% of the reported value, each sized by its share, colored by what the fund did with it since Q4 2019. Striped tiles are options.
Largest buys
Since Q4 2019, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Raytheon Technologies Corp~$1.79BNew · 0.0% → 0.7%+18,942,959 shares
- Comcast Corp Cl A~$1.19BAdded · 0.2% → 0.6%+34,605,876 shares
- Hilton Worldwide Holdings Inc~$966.8MAdded · 0.2% → 0.6%+14,168,234 shares
- Home Depot Inc~$875.7MAdded · 1.1% → 1.5%+4,690,072 shares
- PayPal~$849.5MAdded · 0.2% → 0.5%+8,872,484 shares
- Amazon~$848.8MAdded · 2.3% → 3.4%+435,331 shares
- Gilead Sciences Inc~$811.1MAdded · 1.7% → 2.8%+10,849,434 shares
- Zimmer Biomet Holdings Inc~$792.4MNew · 0.0% → 0.3%+7,839,370 shares
- General Mills Inc~$753.8MAdded · 0.1% → 0.4%+14,283,883 shares
- Canadian Natural Resources Ltd~$607.9MAdded · 0.9% → 0.7%+44,444,284 shares
Largest sells
Since Q4 2019, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Abbvie Inc~$2.85BCut · 2.3% → 1.5%−37,370,388 shares
- Intel~$1.82BCut · 1.0% → 0.5%−33,594,464 shares
- Unitedhealth Group Inc~$1.76BCut · 2.6% → 2.2%−7,072,207 shares
- Fidelity National Information Svs Inc~$1.48BCut · 0.5% → 0.0%−12,193,054 shares
- Abbott Laboratories~$1.41BCut · 3.0% → 3.0%−17,821,395 shares
- Jpmorgan Chase And Co~$1.35BCut · 1.2% → 0.4%−14,948,902 shares
- Humana Inc~$1.30BCut · 0.9% → 0.5%−4,124,660 shares
- Illumina Inc~$1.03BCut · 0.8% → 0.5%−3,772,705 shares
- Cigna Corp~$966.1MCut · 0.6% → 0.3%−5,452,758 shares
- General Dynamics Corp~$892.7MCut · 1.2% → 0.9%−6,746,748 shares
Holdings
As of Mar 31, 2020. Changes are in shares against Dec 31, 2019, so a price move alone never reads as a buy or a sale.
| Holding | Value | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| MicrosoftCOMMON STOCK · shares +0.5% · price +0.0% | 5.8% | $14.71B | +$938,021 | ||||||||
| NetflixCOMMON STOCK · shares −0.2% · price +16.0% | 5.6% | $14.24B | +$1.97B | ||||||||
| MetaCOMMON STOCK · shares −1.1% · price −18.7% | 4.7% | $12.06B | −$2.78B | ||||||||
| AmazonCOMMON STOCK · shares +11% · price +5.5% | 3.4% | $8.78B | +$414.3M | ||||||||
| Abbott LaboratoriesCOMMON STOCK · shares −16% · price −9.2% | 3.0% | $7.56B | −$762.1M | ||||||||
| Gilead Sciences IncCOMMON STOCK · shares +13% · price +15.1% | 2.8% | $7.18B | +$832.6M | ||||||||
| BroadcomCOMMON STOCK · shares +8.6% · price −25.0% | 2.7% | $6.99B | −$2.14B | ||||||||
| Amgen IncCOMMON STOCK · shares −6.3% · price −15.9% | 2.6% | $6.71B | −$1.27B | ||||||||
| Unitedhealth Group IncCOMMON STOCK · shares −24% · price −15.2% | 2.2% | $5.68B | −$1.02B | ||||||||
| AlibabaCOMMON STOCK · shares −9.0% · price −8.3% | 2.0% | $5.01B | −$453.8M | ||||||||
| Home Depot IncCOMMON STOCK · shares +29% · price −14.5% | 1.5% | $3.93B | −$518.8M | ||||||||
| Abbvie IncCOMMON STOCK · shares −43% · price −13.9% | 1.5% | $3.75B | −$608.0M | ||||||||
| MastercardCOMMON STOCK · shares −15% · price −19.1% | 1.4% | $3.65B | −$861.7M | ||||||||
| AlphabetCOMMON STOCK · shares −5.5% · price −13.2% | 1.4% | $3.60B | −$550.3M | ||||||||
| Thermo Fisher Scientific IncCOMMON STOCK · shares −0.09% · price −12.7% | 1.3% | $3.34B | −$486.4M | ||||||||
| AlphabetCOMMON STOCK · shares −9.6% · price −13.0% | 1.2% | $3.07B | −$460.1M | ||||||||
| Philip Morris InternationalCOMMON STOCK · shares −2.2% · price −14.3% | 1.1% | $2.82B | −$468.7M | ||||||||
| Csx CorpCOMMON STOCK · shares −15% · price −20.8% | 1.0% | $2.64B | −$694.1M | ||||||||
| Accenture Plc Cl ACOMMON STOCK · shares +2.4% · price −22.5% | 0.96% | $2.45B | −$694.1M | ||||||||
| AutodeskCOMMON STOCK · shares +29% · price −14.9% | 0.91% | $2.31B | −$314.4M | ||||||||
| AppleCOMMON STOCK · shares +29% · price −13.4% | 0.88% | $2.25B | −$269.4M | ||||||||
| Eog Resources IncCOMMON STOCK · shares +2.4% · price −57.1% | 0.87% | $2.23B | −$2.90B | ||||||||
| General Dynamics CorpCOMMON STOCK · shares −29% · price −25.0% | 0.86% | $2.19B | −$729.2M | ||||||||
| Cme Group Inc Cl ACOMMON STOCK · shares −7.7% · price −13.9% | 0.85% | $2.17B | −$349.2M | ||||||||
| Linde PlcCOMMON STOCK · shares −20% · price −18.6% | 0.85% | $2.16B | −$494.1M | ||||||||
| Total · 397 positions | 100% | $254.90B | −$52.42B |
Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.
What made money
From Q4 2019 to Q1 2020: 354 stocks held throughout, down $52.42B (−18.6%).
- Netflix+$1.97B+16%
- Gilead Sciences Inc+$832.6M+15%
- Amazon+$414.3M+6%
- DocuSign+$118.5M+25%
- Digital Realty+$100.1M+16%
- Exxon Mobil Corp−$1.44B−46%
- Canadian Natural Resources Ltd−$1.68B−58%
- Broadcom−$2.14B−25%
- Meta−$2.78B−19%
- Eog Resources Inc−$2.90B−57%
Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out, 3 splits read into the share counts.
Reported value by quarter
The total value of each quarter's 13F at that quarter end. It moves with prices as well as with buying and selling. Pick a quarter to see what the fund held then.
Every quarter's filing
| Quarter | Reported value | Filing | |
|---|---|---|---|
| Q2 2026 | Aug 12, 2026 | $716.87B+11% | SEC ↗ |
| Q1 2026 | May 13, 2026 | $644.56B+19% | SEC ↗ |
| Q4 2025 | Feb 11, 2026 | $541.73B+2% | SEC ↗ |
| Q3 2025 | Nov 13, 2025 | $532.97B+7% | SEC ↗ |
| Q2 2025 | Aug 13, 2025 | $499.46B+9% | SEC ↗ |
| Q1 2025 | May 12, 2025 | $459.90B−5% | SEC ↗ |
| Q4 2024 | Feb 13, 2025 | $486.38B+1% | SEC ↗ |
| Q3 2024 | Nov 13, 2024 | $481.14B+6% | SEC ↗ |
| Q2 2024 | Aug 13, 2024 | $455.74B+3% | SEC ↗ |
| Q1 2024 | May 14, 2024 | $441.98B+9% | SEC ↗ |
| Q4 2023 | Feb 13, 2024 | $406.47B+12% | SEC ↗ |
| Q3 2023 | Nov 13, 2023 | $363.16B−3% | SEC ↗ |
| Q2 2023 | Aug 11, 2023 | $373.18B+7% | SEC ↗ |
| Q1 2023 | May 15, 2023 | $350.40B+6% | SEC ↗ |
| Q4 2022 | Feb 14, 2023 | $330.88B+9% | SEC ↗ |
| Q3 2022 | Nov 14, 2022 | $304.37B−5% | SEC ↗ |
| Q2 2022 | Aug 15, 2022 | $321.05B−21% | SEC ↗ |
| Q1 2022 | May 19, 2022 (amended) | $405.10B−11% | SEC ↗ |
| Q4 2021 | Feb 14, 2022 | $452.67B+6% | SEC ↗ |
| Q3 2021 | Nov 15, 2021 | $428.65B−0% | SEC ↗ |
| Q2 2021 | Aug 16, 2021 | $429.52B+5% | SEC ↗ |
| Q1 2021 | May 14, 2021 | $408.71B+6% | SEC ↗ |
| Q4 2020 | Feb 12, 2021 | $385.30B+16% | SEC ↗ |
| Q3 2020 | Nov 13, 2020 | $333.11B+5% | SEC ↗ |
| Q2 2020 | Aug 14, 2020 | $316.13B+24% | SEC ↗ |
| Q1 2020 | May 15, 2020 | $254.90B−24% | SEC ↗ |
| Q4 2019 | Feb 18, 2020 | $333.48B+9% | SEC ↗ |
| Q3 2019 | Nov 14, 2019 | $304.85B−3% | SEC ↗ |
| Q2 2019 | Aug 14, 2019 | $314.99B−0% | SEC ↗ |
| Q1 2019 | May 15, 2019 | $315.45B+10% | SEC ↗ |
| Q4 2018 | Feb 14, 2019 | $287.02B−17% | SEC ↗ |
| Q3 2018 | Nov 14, 2018 | $344.02B−6% | SEC ↗ |
| Q2 2018 | Aug 14, 2018 | $366.12B+4% | SEC ↗ |
| Q1 2018 | May 15, 2018 | $351.43B+3% | SEC ↗ |
| Q4 2017 | Feb 14, 2018 | $340.76B+3% | SEC ↗ |
| Q3 2017 | Nov 14, 2017 | $331.24B+4% | SEC ↗ |
| Q2 2017 | Aug 14, 2017 | $319.49B+1% | SEC ↗ |
| Q1 2017 | May 15, 2017 | $317.04B+3% | SEC ↗ |
| Q4 2016 | Feb 15, 2017 | $308.47B+2% | SEC ↗ |
| Q3 2016 | Nov 14, 2016 | $302.53B+3% | SEC ↗ |
| Q2 2016 | Aug 15, 2016 | $292.47B+1% | SEC ↗ |
| Q1 2016 | May 16, 2016 | $290.06B | SEC ↗ |